Should you buy Globus Medical stock now?
The technical signal for Globus Medical is currently NEUTRAL. Globus Medical trades at $79.85 as of 8/6/2026. The overall technical signal is: Hold. The technical analysis shows the following: MACD is positive (bullish trend) at 0.331 with rising momentum (signal: -0.195); RSI is at 53.0 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $103.92 points to 30.1% upside. This is a technical observation based on current data, not investment advice.
What is the price target for Globus Medical stock?
The average analyst price target for Globus Medical is $103.92. The current price is $79.85, which gives an upside of 30.1%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $93.53 and $114.31.
Is Globus Medical a dividend stock?
No, Globus Medical does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Globus Medical stock?
Globus Medical is rated as a stock with high risk. the annual standard deviation is 49.6%, which classifies the stock as high risk.
Is Globus Medical overvalued?
No, Globus Medical is considered undervalued based on the analyst price target (30.1% upside). Globus Medical has the following valuation ratios: a P/E ratio of 19.0 (moderately valued), a P/S ratio of 3.6, a P/B ratio of 2.3. The analyst price target suggests that the stock is undervalued by 30.1%.
Is Globus Medical overbought?
No, Globus Medical is not overbought. RSI is at 53.0 (neutral zone). The technical indicators show: RSI is at 53.0 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 1.8% above the 20-day average (short-term uptrend). In addition, MACD is positive with rising momentum (bullish).
When is the next Globus Medical earnings report?
Globus Medical reports earnings TODAY, August 6, 2026! The stock currently trades at $79.85. Watch how the price reacts after the release. With a P/E ratio of 19.0, the market will be watching closely whether earnings meet expectations.
Is Globus Medical shorted?
Yes, Globus Medical is shorted with 6.3% of the free float sold short. This is a high level of short selling, which suggests some investors are betting on falling prices. Positive surprises can lead to a moderate short squeeze. Data is updated daily based on official filings with the SEC.
Are insiders buying Globus Medical stock?
No, insiders are not buying Globus Medical shares – they are net sellers. Over the last 3 months, insiders have made 1 purchases and 1 sales. On a net basis, 1,362,250 $ worth of shares were sold. Across the last 20 reported transactions, the split is 2 purchases and 18 sales, with a net 19,366,327 $ sold. Active sellers include Davidar David D, Kelly Huller, Huller Kelly and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Globus Medical a good stock?
Based on our total score, Globus Medical is rated as a good stock with a total score of 65 out of 100. The stock scores above average on value, quality and momentum – it is among the top 35% in our database. The score is made up of Value: 67/100, Quality: 84/100, Momentum: 43/100. In addition: analysts see 30.1% upside to the price target; technical signal: Hold. Whether Globus Medical is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Globus Medical stock?
The outlook for Globus Medical based on current data: the average analyst price target is $103.92 (+30.1%); the next earnings report is due on 8/6/2026, which can move the price; the P/E ratio is 19.0 (moderate). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Globus Medical stock moving?
Globus Medical is stable right now. The technical indicators show: the price is close to the 20-day average; MACD is positive with rising momentum (bullish signal); short interest is 6.3% (high – many are betting on a decline); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can Globus Medical go?
The average analyst price target for Globus Medical is $103.92, which corresponds to a potential gain of 30.1% from the current price of $79.85. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Globus Medical fall?
We lack enough history to give a specific floor for Globus Medical. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Globus Medical do?
Globus Medical, Inc. driver en virksomhed, der udvikler og sælger medicinsk udstyr til behandling af problemer med muskler og knogler. De tjener primært penge på at levere løsninger til rygkirurgi, både i USA og internationalt.
Globus Medical laver traditionelle fusionsimplan... The company belongs to the Sundhed sector, more specifically the Medicinprodukter industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Globus Medical as an investment.
Did Globus Medical raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Globus Medical. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is Globus Medical making money or losing money?
Yes, Globus Medical is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 18.9% — which is solid. The operating margin (profit before interest and taxes) is 21.3%. At a P/E ratio of 19.0, you currently pay 19.0 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can Globus Medical go bankrupt?
The bankruptcy risk of Globus Medical is rated as low. Altman Z2 (a model for assessing financial distress) is 10.74 — that places the company in the healthy zone. The company has a healthy balance sheet with limited debt relative to earnings and assets. The Piotroski score (financial health 0-9, higher is better) is 8 — which is strong. Debt relative to equity is 26% (low). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Globus Medical have a lot of debt?
No, Globus Medical has low debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 26%. For the sundhed sector, anything below 80% counts as low debt. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can Globus Medical service its debt? Can service its debt without problems — the interest coverage ratio (how many times earnings can cover interest payments) is 28.9x, and the company has more cash than debt (net cash).
